| Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials AS Strimpakos, RA Sharma Antioxidants & redox signaling 10 (3), 511-546, 2008 | 815 | 2008 |
| A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for … R Wong, D Cunningham, Y Barbachano, C Saffery, J Valle, T Hickish, ... Annals of Oncology 22 (9), 2042-2048, 2011 | 262 | 2011 |
| The role of mTOR in the management of solid tumors: an overview AS Strimpakos, EM Karapanagiotou, MW Saif, KN Syrigos Cancer treatment reviews 35 (2), 148-159, 2009 | 202 | 2009 |
| Pancreatic cancer: from molecular pathogenesis to targeted therapy A Strimpakos, MW Saif, KN Syrigos Cancer and Metastasis Reviews 27 (3), 495-522, 2008 | 127 | 2008 |
| The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy AS Strimpakos, D Cunningham, C Mikropoulos, I Petkar, Y Barbachano, ... Annals of Oncology 21 (5), 1013-1019, 2010 | 62 | 2010 |
| Update on phase I studies in advanced pancreatic adenocarcinoma. Hunting in darkness? AS Strimpakos, MW Saif JOP. Journal of the Pancreas 14 (4), 354-358, 2013 | 42 | 2013 |
| Pharmacogenetics and biomarkers in colorectal cancer AS Strimpakos, KN Syrigos, MW Saif The pharmacogenomics journal 9 (3), 147-160, 2009 | 40 | 2009 |
| The molecular targets for the diagnosis and treatment of pancreatic cancer AS Strimpakos, KN Syrigos, MW Saif Gut and liver 4 (4), 433, 2010 | 39 | 2010 |
| Histones and lung cancer: Are the histone deacetylases a promising therapeutic target? V Petta, I Gkiozos, A Strimpakos, K Syrigos Cancer chemotherapy and pharmacology 72, 935-952, 2013 | 33 | 2013 |
| The role of endobronchial ultrasound in lung cancer diagnosis and staging: a comprehensive review I Kokkonouzis, AS Strimpakos, I Lampaditis, S Tsimpoukis, KN Syrigos Clinical Lung Cancer 13 (6), 408-415, 2012 | 33 | 2012 |
| The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab A Strimpakos, G Pentheroudakis, V Kotoula, W De Roock, G Kouvatseas, ... Clinical colorectal cancer 12 (4), 267-274. e2, 2013 | 32 | 2013 |
| Biomarkers and pharmacogenetics in pancreatic cancer X Xu, AS Strimpakos, MW Saif JOP. Journal of the Pancreas 12 (4), 325-329, 2011 | 22 | 2011 |
| Translational research in pancreatic cancer AS Strimpakos, KN Syrigos, MW Saif J Pancreas (online) 12 (2), 120-122, 2011 | 22 | 2011 |
| The efficacy of gemcitabine as salvage treatment in patients with refractory advanced colorectal cancer (CRC): a single institution experience MW Saif, K Kaley, R Penney, S Hotchkiss, KN Syrigos, AS Strimpakos Anticancer research 31 (9), 2971-2974, 2011 | 19 | 2011 |
| The clinical significance of cytology versus histology-based diagnosis in small cell lung cancer: A retrospective study A Strimpakos, E Politi, E Kainis, D Grapsa, S Siolos, S Tsagouli, ... Lung Cancer 85 (2), 186-190, 2014 | 11 | 2014 |
| Novel agents and new combination treatments on phase I studies on solid tumors and pancreatic cancer AS Strimpakos, KN Syrigos, MW Saif JOP. Journal of the Pancreas 13 (4), 345-348, 2012 | 11 | 2012 |
| Pharmacogenetics in Pancreatic Cancer AS Strimpakos, KN Syrigos, MW Saif JOP. J Pancreas (Online) 10 (4), 357-360, 2009 | 11 | 2009 |
| Novel agents in early phase clinical studies on refractory pancreatic cancer AS Strimpakos, KN Syrigos, MW Saif JOP. Journal of the Pancreas 13 (2), 166-168, 2012 | 10 | 2012 |
| Azithromycin pulses for the treatment of epidermal growth factor receptor inhibitor-related papulopustular eruption: an effective and convenient alternative to tetracyclines V Nikolaou, AS Strimpakos, A Stratigos, A Katsambas, C Antoniou, ... Dermatology 224 (4), 315-319, 2012 | 9 | 2012 |
| Pancreatic neuroendocrine tumors: role of novel agents AS Strimpakos, KN Syrigos, MW Saif JOP. Journal of the Pancreas 12 (2), 117-119, 2011 | 8 | 2011 |
